Literature DB >> 10821813

Assessment of coronary arterial restenosis with phase-contrast magnetic resonance imaging measurements of coronary flow reserve.

W G Hundley1, L D Hillis, C A Hamilton, R J Applegate, D M Herrington, G D Clarke, G A Braden, M S Thomas, R A Lange, R M Peshock, K M Link.   

Abstract

BACKGROUND: After successful percutaneous coronary arterial revascularization, 25% to 60% of subjects have restenosis, a recurrent coronary arterial narrowing at the site of the intervention. At present, restenosis is usually detected invasively with contrast coronary angiography. This study was performed to determine if phase-contrast MRI (PC-MRI) could be used to detect restenosis noninvasively in patients with recurrent chest pain after percutaneous revascularization. METHODS AND
RESULTS: Seventeen patients (15 men, 2 women, age 36 to 77 years) with recurrent chest pain >3 months after successful percutaneous intervention underwent PC-MRI measurements of coronary artery flow reserve followed by assessments of stenosis severity with computer-assisted quantitative coronary angiography. The intervention was performed in the left anterior descending coronary artery in 15 patients, one of its diagonal branches in 2 patients, and the right coronary artery in 1 patient. A PC-MRI coronary flow reserve value </=2.0 was 100% and 82% sensitive and 89% and 100% specific for detecting a luminal diameter narrowing of >/=70% and >/=50%, respectively.
CONCLUSIONS: Assessments of coronary flow reserve with PC-MRI can be used to identify flow-limiting stenoses (luminal diameter narrowings >70%) in patients with recurrent chest pain in the months after a successful percutaneous intervention.

Entities:  

Mesh:

Year:  2000        PMID: 10821813     DOI: 10.1161/01.cir.101.20.2375

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  Magnetic resonance imaging in detection and functional assessment of coronary artery disease.

Authors:  Wojciech Mazur; Steffen Brucks; Stephen N Darty; Pairoj Rerkpattanapipat
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

Review 2.  Future prospects in magnetic resonance imaging.

Authors:  Mark Doyle; Robert W W Biederman
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

Review 3.  Future prospects in cardiac magnetic resonance imaging.

Authors:  Mark Doyle; Robert W W Biederman
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

4.  The value of magnetocardiography in the course of coronary intervention.

Authors:  Birgit Hailer; Peter Van Leeuwen; Illja Chaikovsky; Sabine Auth-Eisernitz; Harald Schäfer; Dietrich Grönemeyer
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

Review 5.  [Flow measurements in cardiac MRI].

Authors:  J Lotz
Journal:  Radiologe       Date:  2007-04       Impact factor: 0.635

6.  Assessment of differential branch pulmonary blood flow: a comparative study of phase contrast magnetic resonance imaging and radionuclide lung perfusion imaging.

Authors:  S Sridharan; G Derrick; J Deanfield; A M Taylor
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

7.  Stent-induced coronary artery stenosis characterized by multimodal nonlinear optical microscopy.

Authors:  Han-Wei Wang; Vlad Simianu; Mattew J Locker; Ji-Xin Cheng; Michael Sturek
Journal:  J Biomed Opt       Date:  2011-02       Impact factor: 3.170

8.  Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2003-11-01

9.  Coronary Endothelial Dysfunction in Women With Type 2 Diabetes Measured by Coronary Phase Contrast Flow Velocity Magnetic Resonance Imaging.

Authors:  Christopher D Maroules; Alice Y Chang; Melanie S Kotys-Traughber; Ronald M Peshock
Journal:  J Investig Med       Date:  2015-10       Impact factor: 2.895

Review 10.  Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease.

Authors:  Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Curr Opin Cardiol       Date:  2008-11       Impact factor: 2.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.